In agreement, we observed that hypermethylation mainly affects nonpromoter CGIs in CP‐CML CD34+CD15− cells, and CGI promoters in solid cancers (Court and Arnaud, 2017). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.